Global Cell and Gene Therapy CRO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

A Cell and Gene Therapy Contract Research Organization (CRO) is a specialized service provider that offers support and expertise in conducting preclinical and clinical research for cell and gene therapy products. These CROs play a crucial role in advancing the development of cell and gene therapies by providing a wide range of services tailored to the unique requirements of these innovative treatments.

According to our (Global Info Research) latest study, the global Cell and Gene Therapy CRO market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Cell and Gene Therapy CRO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Cell and Gene Therapy CRO market size and forecasts, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CRO market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CRO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Cell and Gene Therapy CRO market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy CRO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy CRO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Cell and Gene Therapy CRO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Cell and Gene Therapy CRO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Preclinical CRO
    Clinical CRO

Market segment by Application
    SMBs
    Large Companies

Market segment by players, this report covers
    Labcorp
    IQVIA Biotech
    PPD
    Medpace
    Veristat
    Parexel
    Charles River Laboratories
    Catalent Pharma Solutions
    Premier Research
    Catalent
    Vial
    Noble Life Sciences
    Ergomed

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy CRO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CRO, with revenue, gross margin, and global market share of Cell and Gene Therapy CRO from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy CRO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy CRO market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CRO.
Chapter 13, to describe Cell and Gene Therapy CRO research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy CRO by Type
        1.3.1 Overview: Global Cell and Gene Therapy CRO Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Cell and Gene Therapy CRO Consumption Value Market Share by Type in 2023
        1.3.3 Preclinical CRO
        1.3.4 Clinical CRO
    1.4 Global Cell and Gene Therapy CRO Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy CRO Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 SMBs
        1.4.3 Large Companies
    1.5 Global Cell and Gene Therapy CRO Market Size & Forecast
    1.6 Global Cell and Gene Therapy CRO Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy CRO Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Cell and Gene Therapy CRO Market Size by Region, (2019-2030)
        1.6.3 North America Cell and Gene Therapy CRO Market Size and Prospect (2019-2030)
        1.6.4 Europe Cell and Gene Therapy CRO Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Cell and Gene Therapy CRO Market Size and Prospect (2019-2030)
        1.6.6 South America Cell and Gene Therapy CRO Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Cell and Gene Therapy CRO Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Labcorp
        2.1.1 Labcorp Details
        2.1.2 Labcorp Major Business
        2.1.3 Labcorp Cell and Gene Therapy CRO Product and Solutions
        2.1.4 Labcorp Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Labcorp Recent Developments and Future Plans
    2.2 IQVIA Biotech
        2.2.1 IQVIA Biotech Details
        2.2.2 IQVIA Biotech Major Business
        2.2.3 IQVIA Biotech Cell and Gene Therapy CRO Product and Solutions
        2.2.4 IQVIA Biotech Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 IQVIA Biotech Recent Developments and Future Plans
    2.3 PPD
        2.3.1 PPD Details
        2.3.2 PPD Major Business
        2.3.3 PPD Cell and Gene Therapy CRO Product and Solutions
        2.3.4 PPD Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 PPD Recent Developments and Future Plans
    2.4 Medpace
        2.4.1 Medpace Details
        2.4.2 Medpace Major Business
        2.4.3 Medpace Cell and Gene Therapy CRO Product and Solutions
        2.4.4 Medpace Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Medpace Recent Developments and Future Plans
    2.5 Veristat
        2.5.1 Veristat Details
        2.5.2 Veristat Major Business
        2.5.3 Veristat Cell and Gene Therapy CRO Product and Solutions
        2.5.4 Veristat Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Veristat Recent Developments and Future Plans
    2.6 Parexel
        2.6.1 Parexel Details
        2.6.2 Parexel Major Business
        2.6.3 Parexel Cell and Gene Therapy CRO Product and Solutions
        2.6.4 Parexel Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Parexel Recent Developments and Future Plans
    2.7 Charles River Laboratories
        2.7.1 Charles River Laboratories Details
        2.7.2 Charles River Laboratories Major Business
        2.7.3 Charles River Laboratories Cell and Gene Therapy CRO Product and Solutions
        2.7.4 Charles River Laboratories Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Charles River Laboratories Recent Developments and Future Plans
    2.8 Catalent Pharma Solutions
        2.8.1 Catalent Pharma Solutions Details
        2.8.2 Catalent Pharma Solutions Major Business
        2.8.3 Catalent Pharma Solutions Cell and Gene Therapy CRO Product and Solutions
        2.8.4 Catalent Pharma Solutions Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Catalent Pharma Solutions Recent Developments and Future Plans
    2.9 Premier Research
        2.9.1 Premier Research Details
        2.9.2 Premier Research Major Business
        2.9.3 Premier Research Cell and Gene Therapy CRO Product and Solutions
        2.9.4 Premier Research Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Premier Research Recent Developments and Future Plans
    2.10 Catalent
        2.10.1 Catalent Details
        2.10.2 Catalent Major Business
        2.10.3 Catalent Cell and Gene Therapy CRO Product and Solutions
        2.10.4 Catalent Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Catalent Recent Developments and Future Plans
    2.11 Vial
        2.11.1 Vial Details
        2.11.2 Vial Major Business
        2.11.3 Vial Cell and Gene Therapy CRO Product and Solutions
        2.11.4 Vial Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Vial Recent Developments and Future Plans
    2.12 Noble Life Sciences
        2.12.1 Noble Life Sciences Details
        2.12.2 Noble Life Sciences Major Business
        2.12.3 Noble Life Sciences Cell and Gene Therapy CRO Product and Solutions
        2.12.4 Noble Life Sciences Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Noble Life Sciences Recent Developments and Future Plans
    2.13 Ergomed
        2.13.1 Ergomed Details
        2.13.2 Ergomed Major Business
        2.13.3 Ergomed Cell and Gene Therapy CRO Product and Solutions
        2.13.4 Ergomed Cell and Gene Therapy CRO Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Ergomed Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy CRO Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Cell and Gene Therapy CRO by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy CRO Players Market Share in 2023
        3.2.3 Top 6 Cell and Gene Therapy CRO Players Market Share in 2023
    3.3 Cell and Gene Therapy CRO Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy CRO Market: Region Footprint
        3.3.2 Cell and Gene Therapy CRO Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy CRO Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy CRO Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Cell and Gene Therapy CRO Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2024)
    5.2 Global Cell and Gene Therapy CRO Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Cell and Gene Therapy CRO Consumption Value by Type (2019-2030)
    6.2 North America Cell and Gene Therapy CRO Market Size by Application (2019-2030)
    6.3 North America Cell and Gene Therapy CRO Market Size by Country
        6.3.1 North America Cell and Gene Therapy CRO Consumption Value by Country (2019-2030)
        6.3.2 United States Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        6.3.3 Canada Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        6.3.4 Mexico Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Cell and Gene Therapy CRO Consumption Value by Type (2019-2030)
    7.2 Europe Cell and Gene Therapy CRO Consumption Value by Application (2019-2030)
    7.3 Europe Cell and Gene Therapy CRO Market Size by Country
        7.3.1 Europe Cell and Gene Therapy CRO Consumption Value by Country (2019-2030)
        7.3.2 Germany Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        7.3.3 France Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        7.3.5 Russia Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        7.3.6 Italy Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Cell and Gene Therapy CRO Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Region (2019-2030)
        8.3.2 China Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        8.3.3 Japan Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        8.3.4 South Korea Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        8.3.5 India Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        8.3.7 Australia Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Cell and Gene Therapy CRO Consumption Value by Type (2019-2030)
    9.2 South America Cell and Gene Therapy CRO Consumption Value by Application (2019-2030)
    9.3 South America Cell and Gene Therapy CRO Market Size by Country
        9.3.1 South America Cell and Gene Therapy CRO Consumption Value by Country (2019-2030)
        9.3.2 Brazil Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        9.3.3 Argentina Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Cell and Gene Therapy CRO Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Country (2019-2030)
        10.3.2 Turkey Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)
        10.3.4 UAE Cell and Gene Therapy CRO Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Cell and Gene Therapy CRO Market Drivers
    11.2 Cell and Gene Therapy CRO Market Restraints
    11.3 Cell and Gene Therapy CRO Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy CRO Industry Chain
    12.2 Cell and Gene Therapy CRO Upstream Analysis
    12.3 Cell and Gene Therapy CRO Midstream Analysis
    12.4 Cell and Gene Therapy CRO Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cell and Gene Therapy CRO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Cell and Gene Therapy CRO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Cell and Gene Therapy CRO Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Cell and Gene Therapy CRO Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Labcorp Company Information, Head Office, and Major Competitors
 Table 6. Labcorp Major Business
 Table 7. Labcorp Cell and Gene Therapy CRO Product and Solutions
 Table 8. Labcorp Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Labcorp Recent Developments and Future Plans
 Table 10. IQVIA Biotech Company Information, Head Office, and Major Competitors
 Table 11. IQVIA Biotech Major Business
 Table 12. IQVIA Biotech Cell and Gene Therapy CRO Product and Solutions
 Table 13. IQVIA Biotech Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. IQVIA Biotech Recent Developments and Future Plans
 Table 15. PPD Company Information, Head Office, and Major Competitors
 Table 16. PPD Major Business
 Table 17. PPD Cell and Gene Therapy CRO Product and Solutions
 Table 18. PPD Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Medpace Company Information, Head Office, and Major Competitors
 Table 20. Medpace Major Business
 Table 21. Medpace Cell and Gene Therapy CRO Product and Solutions
 Table 22. Medpace Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Medpace Recent Developments and Future Plans
 Table 24. Veristat Company Information, Head Office, and Major Competitors
 Table 25. Veristat Major Business
 Table 26. Veristat Cell and Gene Therapy CRO Product and Solutions
 Table 27. Veristat Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Veristat Recent Developments and Future Plans
 Table 29. Parexel Company Information, Head Office, and Major Competitors
 Table 30. Parexel Major Business
 Table 31. Parexel Cell and Gene Therapy CRO Product and Solutions
 Table 32. Parexel Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Parexel Recent Developments and Future Plans
 Table 34. Charles River Laboratories Company Information, Head Office, and Major Competitors
 Table 35. Charles River Laboratories Major Business
 Table 36. Charles River Laboratories Cell and Gene Therapy CRO Product and Solutions
 Table 37. Charles River Laboratories Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Charles River Laboratories Recent Developments and Future Plans
 Table 39. Catalent Pharma Solutions Company Information, Head Office, and Major Competitors
 Table 40. Catalent Pharma Solutions Major Business
 Table 41. Catalent Pharma Solutions Cell and Gene Therapy CRO Product and Solutions
 Table 42. Catalent Pharma Solutions Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Catalent Pharma Solutions Recent Developments and Future Plans
 Table 44. Premier Research Company Information, Head Office, and Major Competitors
 Table 45. Premier Research Major Business
 Table 46. Premier Research Cell and Gene Therapy CRO Product and Solutions
 Table 47. Premier Research Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Premier Research Recent Developments and Future Plans
 Table 49. Catalent Company Information, Head Office, and Major Competitors
 Table 50. Catalent Major Business
 Table 51. Catalent Cell and Gene Therapy CRO Product and Solutions
 Table 52. Catalent Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. Catalent Recent Developments and Future Plans
 Table 54. Vial Company Information, Head Office, and Major Competitors
 Table 55. Vial Major Business
 Table 56. Vial Cell and Gene Therapy CRO Product and Solutions
 Table 57. Vial Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Vial Recent Developments and Future Plans
 Table 59. Noble Life Sciences Company Information, Head Office, and Major Competitors
 Table 60. Noble Life Sciences Major Business
 Table 61. Noble Life Sciences Cell and Gene Therapy CRO Product and Solutions
 Table 62. Noble Life Sciences Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. Noble Life Sciences Recent Developments and Future Plans
 Table 64. Ergomed Company Information, Head Office, and Major Competitors
 Table 65. Ergomed Major Business
 Table 66. Ergomed Cell and Gene Therapy CRO Product and Solutions
 Table 67. Ergomed Cell and Gene Therapy CRO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. Ergomed Recent Developments and Future Plans
 Table 69. Global Cell and Gene Therapy CRO Revenue (USD Million) by Players (2019-2024)
 Table 70. Global Cell and Gene Therapy CRO Revenue Share by Players (2019-2024)
 Table 71. Breakdown of Cell and Gene Therapy CRO by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 72. Market Position of Players in Cell and Gene Therapy CRO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 73. Head Office of Key Cell and Gene Therapy CRO Players
 Table 74. Cell and Gene Therapy CRO Market: Company Product Type Footprint
 Table 75. Cell and Gene Therapy CRO Market: Company Product Application Footprint
 Table 76. Cell and Gene Therapy CRO New Market Entrants and Barriers to Market Entry
 Table 77. Cell and Gene Therapy CRO Mergers, Acquisition, Agreements, and Collaborations
 Table 78. Global Cell and Gene Therapy CRO Consumption Value (USD Million) by Type (2019-2024)
 Table 79. Global Cell and Gene Therapy CRO Consumption Value Share by Type (2019-2024)
 Table 80. Global Cell and Gene Therapy CRO Consumption Value Forecast by Type (2025-2030)
 Table 81. Global Cell and Gene Therapy CRO Consumption Value by Application (2019-2024)
 Table 82. Global Cell and Gene Therapy CRO Consumption Value Forecast by Application (2025-2030)
 Table 83. North America Cell and Gene Therapy CRO Consumption Value by Type (2019-2024) & (USD Million)
 Table 84. North America Cell and Gene Therapy CRO Consumption Value by Type (2025-2030) & (USD Million)
 Table 85. North America Cell and Gene Therapy CRO Consumption Value by Application (2019-2024) & (USD Million)
 Table 86. North America Cell and Gene Therapy CRO Consumption Value by Application (2025-2030) & (USD Million)
 Table 87. North America Cell and Gene Therapy CRO Consumption Value by Country (2019-2024) & (USD Million)
 Table 88. North America Cell and Gene Therapy CRO Consumption Value by Country (2025-2030) & (USD Million)
 Table 89. Europe Cell and Gene Therapy CRO Consumption Value by Type (2019-2024) & (USD Million)
 Table 90. Europe Cell and Gene Therapy CRO Consumption Value by Type (2025-2030) & (USD Million)
 Table 91. Europe Cell and Gene Therapy CRO Consumption Value by Application (2019-2024) & (USD Million)
 Table 92. Europe Cell and Gene Therapy CRO Consumption Value by Application (2025-2030) & (USD Million)
 Table 93. Europe Cell and Gene Therapy CRO Consumption Value by Country (2019-2024) & (USD Million)
 Table 94. Europe Cell and Gene Therapy CRO Consumption Value by Country (2025-2030) & (USD Million)
 Table 95. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Type (2019-2024) & (USD Million)
 Table 96. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Type (2025-2030) & (USD Million)
 Table 97. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Application (2019-2024) & (USD Million)
 Table 98. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Application (2025-2030) & (USD Million)
 Table 99. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Region (2019-2024) & (USD Million)
 Table 100. Asia-Pacific Cell and Gene Therapy CRO Consumption Value by Region (2025-2030) & (USD Million)
 Table 101. South America Cell and Gene Therapy CRO Consumption Value by Type (2019-2024) & (USD Million)
 Table 102. South America Cell and Gene Therapy CRO Consumption Value by Type (2025-2030) & (USD Million)
 Table 103. South America Cell and Gene Therapy CRO Consumption Value by Application (2019-2024) & (USD Million)
 Table 104. South America Cell and Gene Therapy CRO Consumption Value by Application (2025-2030) & (USD Million)
 Table 105. South America Cell and Gene Therapy CRO Consumption Value by Country (2019-2024) & (USD Million)
 Table 106. South America Cell and Gene Therapy CRO Consumption Value by Country (2025-2030) & (USD Million)
 Table 107. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Type (2019-2024) & (USD Million)
 Table 108. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Type (2025-2030) & (USD Million)
 Table 109. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Application (2019-2024) & (USD Million)
 Table 110. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Application (2025-2030) & (USD Million)
 Table 111. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Country (2019-2024) & (USD Million)
 Table 112. Middle East & Africa Cell and Gene Therapy CRO Consumption Value by Country (2025-2030) & (USD Million)
 Table 113. Global Key Players of Cell and Gene Therapy CRO Upstream (Raw Materials)
 Table 114. Global Cell and Gene Therapy CRO Typical Customers


List of Figures
 Figure 1. Cell and Gene Therapy CRO Picture
 Figure 2. Global Cell and Gene Therapy CRO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Cell and Gene Therapy CRO Consumption Value Market Share by Type in 2023
 Figure 4. Preclinical CRO
 Figure 5. Clinical CRO
 Figure 6. Global Cell and Gene Therapy CRO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Cell and Gene Therapy CRO Consumption Value Market Share by Application in 2023
 Figure 8. SMBs Picture
 Figure 9. Large Companies Picture
 Figure 10. Global Cell and Gene Therapy CRO Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Cell and Gene Therapy CRO Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Market Cell and Gene Therapy CRO Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 13. Global Cell and Gene Therapy CRO Consumption Value Market Share by Region (2019-2030)
 Figure 14. Global Cell and Gene Therapy CRO Consumption Value Market Share by Region in 2023
 Figure 15. North America Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 16. Europe Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 17. Asia-Pacific Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 18. South America Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 19. Middle East & Africa Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Cell and Gene Therapy CRO Revenue Share by Players in 2023
 Figure 22. Cell and Gene Therapy CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 23. Market Share of Cell and Gene Therapy CRO by Player Revenue in 2023
 Figure 24. Top 3 Cell and Gene Therapy CRO Players Market Share in 2023
 Figure 25. Top 6 Cell and Gene Therapy CRO Players Market Share in 2023
 Figure 26. Global Cell and Gene Therapy CRO Consumption Value Share by Type (2019-2024)
 Figure 27. Global Cell and Gene Therapy CRO Market Share Forecast by Type (2025-2030)
 Figure 28. Global Cell and Gene Therapy CRO Consumption Value Share by Application (2019-2024)
 Figure 29. Global Cell and Gene Therapy CRO Market Share Forecast by Application (2025-2030)
 Figure 30. North America Cell and Gene Therapy CRO Consumption Value Market Share by Type (2019-2030)
 Figure 31. North America Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2030)
 Figure 32. North America Cell and Gene Therapy CRO Consumption Value Market Share by Country (2019-2030)
 Figure 33. United States Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 34. Canada Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 35. Mexico Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 36. Europe Cell and Gene Therapy CRO Consumption Value Market Share by Type (2019-2030)
 Figure 37. Europe Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2030)
 Figure 38. Europe Cell and Gene Therapy CRO Consumption Value Market Share by Country (2019-2030)
 Figure 39. Germany Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 40. France Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 41. United Kingdom Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 42. Russia Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 43. Italy Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 44. Asia-Pacific Cell and Gene Therapy CRO Consumption Value Market Share by Type (2019-2030)
 Figure 45. Asia-Pacific Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2030)
 Figure 46. Asia-Pacific Cell and Gene Therapy CRO Consumption Value Market Share by Region (2019-2030)
 Figure 47. China Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 48. Japan Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 49. South Korea Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 50. India Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 51. Southeast Asia Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 52. Australia Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 53. South America Cell and Gene Therapy CRO Consumption Value Market Share by Type (2019-2030)
 Figure 54. South America Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2030)
 Figure 55. South America Cell and Gene Therapy CRO Consumption Value Market Share by Country (2019-2030)
 Figure 56. Brazil Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 57. Argentina Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 58. Middle East & Africa Cell and Gene Therapy CRO Consumption Value Market Share by Type (2019-2030)
 Figure 59. Middle East & Africa Cell and Gene Therapy CRO Consumption Value Market Share by Application (2019-2030)
 Figure 60. Middle East & Africa Cell and Gene Therapy CRO Consumption Value Market Share by Country (2019-2030)
 Figure 61. Turkey Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 62. Saudi Arabia Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 63. UAE Cell and Gene Therapy CRO Consumption Value (2019-2030) & (USD Million)
 Figure 64. Cell and Gene Therapy CRO Market Drivers
 Figure 65. Cell and Gene Therapy CRO Market Restraints
 Figure 66. Cell and Gene Therapy CRO Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Cell and Gene Therapy CRO Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Companies Mentioned

Labcorp
IQVIA Biotech
PPD
Medpace
Veristat
Parexel
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed